It is with our utmost pleasure to announce Dr. Koh, Jong Sung as the winner of 2015 Daewoong-KASBP Achievement Award. Dr. Koh will deliver the awardee lecture at the upcoming KASBP Fall Symposium. Please join us in congratulating him on the award and celebrating his great achievement in drug development at the symposium. Dr. Koh's biographical sketch as well as the abstract of his talk is shown below.
---------------
Joyful journeys to create, add, and promote value as a new drug discoverer
Jong Sung Koh, Ph.D., Chief Technology Officer, Genosco
New drug discovery and development is like a marathon that requires endurance and commitment. Success in making new medicine requires immense resources and a deeper understanding of rigorous R&D process. It also takes persistence and sometimes, luck. Ultimately, though, discovery of new medicine brings hope and relief to millions of patients. In that sense, the process of drug discovery is a joyful journey if you enjoy the scientific process of making a new medicine. However, there are also often many dead ends and setbacks. To overcome the agonies in the dead ends and setbacks, drug discoverer needs high adversity quotient (AQ) to turn obstacles into opportunities.
Over 25 years, I have been involved in new drug discovery in the areas of anti-HIV, anti-diabetes, anti-cancers, and rheumatoid arthritis. This talk presents my journey as a drug discoverer and immense satisfaction it has given me over the years. The audacious journey from Deaduk Science town to Cambridge is also presented.
2008 ~ present
|
CTO, GENOSCO & President, KABIC
|
2007 ~ 2008
|
Head, Korea Research Institute of Chemical Technology (KRICT)
(Anti-Cancer Research Center)
|
2005 ~ 2007
|
Managing Director, Vice President, LG Life Sciences, Ltd.
|
2001 ~ 2005
|
Vice president, Drug Discovery, LG Life Sciences, Ltd.
(Anti-Diabetes)
|
1991 ~ 2000
|
Group Leader, LG Chem, Ltd.
(Anti-Cancer & HTS)
|
1995 ~ 1996
|
Visiting Scholar, Department of Chemistry, UC Berkeley
(Combinatorial Chemistry)
|
1990 ~ 1991
|
Senior Research Associate, The Scripps Research Institute
(Catalytic Antibody & Phage Display)
|
1981 ~ 1985
|
Senior Research Scientist, Lucky Ltd.
|
|
|